Cambridge Trust’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-6,851
Closed -$483K 274
2016
Q3
$483K Sell
6,851
-400
-6% -$29.9K 0.04% 177
2016
Q2
$549K Buy
7,251
+3,200
+79% +$235K 0.04% 160
2016
Q1
$279K Buy
4,051
+200
+5% +$14.4K 0.02% 192
2015
Q4
$336K Buy
3,851
+950
+33% +$81.4K 0.03% 171
2015
Q3
$235K Buy
2,901
+74
+3% +$6.45K 0.02% 193
2015
Q2
$251K Buy
2,827
+157
+6% +$13.7K 0.02% 191
2015
Q1
$232K Buy
+2,670
New +$224K 0.02% 204
2014
Q3
Sell
-2,933
Closed -$203K 217
2014
Q2
$203K Sell
2,933
-200
-6% -$14.1K 0.02% 203
2014
Q1
$235K Sell
3,133
-60
-2% -$4.49K 0.02% 182
2013
Q4
$224K Buy
+3,193
New +$209K 0.02% 184

Other funds holding ESRX

Cambridge Trust's ESRX Position: Q4 2016 in Review

Cambridge Trust sold out of Express Scripts Holding Company (ESRX) in Q4 2016, closing a stake of 6,851 shares — an estimated $483K sold.

Cambridge Trust first reported a position in ESRX in Q4 2013 and held it in 10 quarters. The position peaked at $549K in Q2 2016. 1,151 funds tracked by Wall St. Rank hold ESRX as of Q4 2016.

  • Cambridge Trust reported no remaining Express Scripts Holding Company position as of Q4 2016 after selling out during the quarter.
  • Cambridge Trust sold 6,851 Express Scripts Holding Company shares in Q4 2016, an estimated $483K.
  • Cambridge Trust first reported a position in Express Scripts Holding Company in Q4 2013 and held it in 10 quarters.
  • Cambridge Trust's Express Scripts Holding Company position peaked at $549K in Q2 2016.
  • 1,151 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2016.

Based on Cambridge Trust's 13F filing for Q4 2016, filed 3 Feb 2017.